XSTOLCLEAN
Market cap10mUSD
Dec 23, Last price
2.07SEK
1D
-10.00%
1Q
-57.76%
IPO
-83.44%
Name
Lifeclean International AB (publ)
Chart & Performance
P/E
—
P/S
2.19
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
2.88%
Rev. gr., 5y
83.22%
Revenues
53m
+11.28%
Net income
-44m
L+22.59%
CFO
-35m
L+109.11%
Earnings
Feb 18, 2025
Profile
LifeClean International AB (publ) researches, produces, markets, and sells disinfection products in Sweden. It has developed a patented spore, fungal, biofilm, bacterial, and virus-killing surface disinfection for equipment and surfaces, such as floors, walls, furniture, and general roof surfaces. The company was founded in 2012 and is based in Uddevalla, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||
Revenues | 52,501 11.28% | 47,179 -11.59% | 53,361 67.87% | ||||
Cost of revenue | 32,213 | 30,130 | 86,786 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 20,288 | 17,049 | (33,425) | ||||
NOPBT Margin | 38.64% | 36.14% | |||||
Operating Taxes | (148) | (328) | 174 | ||||
Tax Rate | |||||||
NOPAT | 20,436 | 17,377 | (33,599) | ||||
Net income | (44,238) 22.59% | (36,085) 10.17% | (32,754) 840.67% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 30,213 | 17,700 | |||||
BB yield | -7.99% | -6.69% | |||||
| Debt | |||||||
Debt current | 30,719 | 12,264 | 8,069 | ||||
Long-term debt | 17,120 | 20,115 | 10,470 | ||||
Deferred revenue | 20,115 | 10,470 | |||||
Other long-term liabilities | (20,115) | (10,470) | |||||
Net debt | 39,552 | 20,630 | 9,619 | ||||
| Cash flow | |||||||
Cash from operating activities | (35,457) | (16,956) | (21,794) | ||||
CAPEX | (437) | (3,109) | (1,216) | ||||
Cash from investing activities | (4,537) | (3,129) | (36,512) | ||||
Cash from financing activities | 36,673 | 22,840 | 24,681 | ||||
FCF | 11,269 | 32,148 | (54,425) | ||||
| Balance | |||||||
Cash | 8,287 | 11,608 | 8,853 | ||||
Long term investments | 141 | 67 | |||||
Excess cash | 5,662 | 9,390 | 6,252 | ||||
Stockholders' equity | (148,898) | (102,309) | 867 | ||||
Invested Capital | 198,052 | 148,117 | 66,959 | ||||
ROIC | 11.81% | 16.16% | |||||
ROCE | 39.37% | 35.27% | |||||
| EV | |||||||
Common stock shares outstanding | 47,264 | 43,333 | 41,974 | ||||
Price | 8.00 6.67% | 7.50 19.05% | 6.30 -37.62% | ||||
Market cap | 378,114 16.34% | 324,995 22.90% | 264,435 -36.17% | ||||
EV | 417,666 | 345,625 | 341,157 | ||||
EBITDA | 29,240 | 26,009 | (27,341) | ||||
EV/EBITDA | 14.28 | 13.29 | |||||
Interest | 3,266 | 1,336 | 443 | ||||
Interest/NOPBT | 16.10% | 7.84% | |||||